In Vitro Diagnostics Market is Expected to Reach $92.213 Billion by 2026

ABOUT THIS REPORT

OVERVIEW

In Vitro Diagnostics Market is valued at USD XX Billion in 2019 and is expected to reach USD 92.213 Billion by the end of 2026.

Bizlytik analysts forecast the global In Vitro Diagnostics market to grow at a CAGR of 5.2% during the forecast period, according to their latest market research report.

In vitro diagnostics are medical devices used to perform tests on samples such as tissue or blood that have been taken from the human body. In vitro diagnostics can detect diseases and can be used to monitor a person’s overall health to help prevent, treat, and cure diseases. In vitro diagnostics is also used in precision medicine to identify patients who can be benefited from specific treatments or therapies. The in vitro diagnostics can include next-generation sequencing tests, which scan a person’s DNA to detect genomic variations.

According to the World Health Organization, chronic disease is expected to rise by 57% by 2020. According to the National Health Council, chronic diseases affect approximately 133 Billion Americans, representing more than 40% of the total population in 2018, and it is to grow to by 157 Billion, with 81 Billion having multiple conditions in 2020. The rising incidence of Coronavirus has increased the demand for In Vitro Diagnostics in the current situation. For instance, Coronavirus COVID-19 has affected 195 countries and territories around the world. According to the World Health Organization (WHO), there are more than 380,000 confirmed cases of coronavirus disease around the world, with more than 16,000 deaths. As of March 2020, China has the highest number of Coronavirus cases 81,171 and Italy has the highest number of coronavirus deaths 6,077. Abbott has introduced molecular point-of-care test to detect novel coronavirus. Abbott ID NOW COVID-19 test is the fastest available molecular point-of-care test for detecting coronavirus (COVID-19), delivering positive results in little than five minutes and negative results in 13 minutes. Thus, rising cases of Coronavirus has increased the production of In Vitro Diagnostics test.

Reagents & Kits, Instruments, Data Management Software, and Services in the Product & Service segment of the market scope, the Technology segment is categorized into Immuno Diagnostics, Molecular Diagnostics, Microbiology, Hematology, Clinical Chemistry, and Others, the Application segment is divided into Infectious Diseases, Oncology, Diabetes, Cardiology, Autoimmune Diseases, Nephrology, and Others, and the End User segment is segmented into Laboratories, Hospitals, Academic & Medical Schools, and Point-Of-Care Testing. The report covers value of the global market by Product & Service, Technology, Application, and End User.

The market value of Reagents & Kits was USD XX Billion in 2019, and it is expected to reach USD XX Billion by 2026, growing at a CAGR of 5.1% during 2020-2026. The increasing commercialization of In Vitro Diagnostic reagents & kits, regulatory approval for the products, and partnership between companies to develop reagents & kits and expand their global presence are some of the factors that would propel the growth of the segment.
North America, Europe, Asia Pacific, South America, and Middle East & Africa are taken into consideration at the global In Vitro Diagnostics Value figures. While North America is further categorized into enhancing United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope. South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involving GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America In Vitro Diagnostics market was USD XX Billion in 2019, and it is predicted to reach USD XX Billion by 2026, growing at a CAGR of 5.1% during the forecast period. The Rising cases of chronic and infectious diseases in the U.S and other North American countries, increasing commercialization of In Vitro Diagnostic products, the partnership between companies to develop In Vitro Diagnostic products and expand their global presence, government initiatives towards the support of In Vitro Diagnostic and regulatory approval for the products are some of the factors that would improve the growth prospects of the market.

Major players operating in the In Vitro Diagnostics industry include Abbott Laboratories, Danaher Corporation, Roche Diagnostics, Thermo Fisher Scientific, Siemens AG, Becton, Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, Hologic, Inc., Biomérieux SA, Illumina, Inc., Qiagen, DiaSorin, Luminex Corporation.

The partnership between companies to develop In Vitro Diagnostic products and expand their global presence, regulatory approval for the products, and Increasing commercialization of In Vitro Diagnostic products are some of the strategies adopted by the companies.